Omega Enterprise Value Over E B I T D A from 2010 to 2024

OHI Stock  USD 40.14  0.26  0.65%   
Omega Healthcare's Enterprise Value Over EBITDA is decreasing with slightly volatile movements from year to year. Enterprise Value Over EBITDA is predicted to flatten to 8.76. For the period between 2010 and 2024, Omega Healthcare, Enterprise Value Over EBITDA quarterly trend regression had mean deviation of  1.80 and range of 10.62. View All Fundamentals
 
Enterprise Value Over EBITDA  
First Reported
2010-12-31
Previous Quarter
14.79695401
Current Value
8.76
Quarterly Volatility
2.49098144
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Omega Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Omega Healthcare's main balance sheet or income statement drivers, such as Depreciation And Amortization of 335.7 M, Interest Expense of 247.3 M or Selling General Administrative of 85.6 M, as well as many indicators such as Price To Sales Ratio of 5.5, Dividend Yield of 0.1 or PTB Ratio of 1.26. Omega financial statements analysis is a perfect complement when working with Omega Healthcare Valuation or Volatility modules.
  
Check out the analysis of Omega Healthcare Correlation against competitors.

Latest Omega Healthcare's Enterprise Value Over E B I T D A Growth Pattern

Below is the plot of the Enterprise Value Over E B I T D A of Omega Healthcare Investors over the last few years. It is Omega Healthcare's Enterprise Value Over EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Omega Healthcare's overall financial position and show how it may be relating to other accounts over time.
Enterprise Value Over E B I T D A10 Years Trend
Slightly volatile
   Enterprise Value Over E B I T D A   
       Timeline  

Omega Enterprise Value Over E B I T D A Regression Statistics

Arithmetic Mean14.38
Geometric Mean14.17
Coefficient Of Variation17.32
Mean Deviation1.80
Median14.26
Standard Deviation2.49
Sample Variance6.20
Range10.62
R-Value(0.33)
Mean Square Error5.95
R-Squared0.11
Significance0.23
Slope(0.18)
Total Sum of Squares86.87

Omega Enterprise Value Over E B I T D A History

2024 8.76
2023 14.8
2022 16.04
2021 13.5
2020 16.97
2019 16.52
2018 14.26

About Omega Healthcare Financial Statements

Investors use fundamental indicators, such as Omega Healthcare's Enterprise Value Over E B I T D A, to determine how well the company is positioned to perform in the future. Although Omega Healthcare's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Enterprise Value Over EBITDA 14.80  8.76 

Currently Active Assets on Macroaxis

When determining whether Omega Healthcare Inv offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Omega Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Omega Healthcare Investors Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Omega Healthcare Investors Stock:
Check out the analysis of Omega Healthcare Correlation against competitors.
You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Omega Healthcare. If investors know Omega will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Omega Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.137
Dividend Share
2.68
Earnings Share
1.36
Revenue Per Share
4.03
Quarterly Revenue Growth
0.14
The market value of Omega Healthcare Inv is measured differently than its book value, which is the value of Omega that is recorded on the company's balance sheet. Investors also form their own opinion of Omega Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Omega Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Omega Healthcare's market value can be influenced by many factors that don't directly affect Omega Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Omega Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Omega Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Omega Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.